{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:34:58Z","timestamp":1648600498690},"reference-count":10,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"DOI":"10.1007\/s00347-021-01419-z","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T09:03:03Z","timestamp":1622797383000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pr\u00e4klinische Entwicklungen von Behandlungsm\u00f6glichkeiten f\u00fcr retinale Dystrophien bei der neuronalen Ceroid-Lipofuszinose"],"prefix":"10.1007","author":[{"given":"Udo","family":"Bartsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Bassal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Jankowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"1419_CR1","doi-asserted-by":"publisher","first-page":"14185","DOI":"10.1038\/s41598-019-50726-8","volume":"9","author":"Y Atiskova","year":"2019","unstructured":"Atiskova\u00a0Y, Bartsch\u00a0S, Danyukova\u00a0T et al (2019) Mice deficient in the lysosomal enzyme palmitoyl-protein thioesterase 1 (PPT1) display a\u00a0complex retinal phenotype. Sci Rep 9:14185","journal-title":"Sci Rep"},{"key":"1419_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00347-020-01237-9","volume":"118","author":"S Bartsch","year":"2021","unstructured":"Bartsch\u00a0S, Liu\u00a0J, Bassal\u00a0M et\u00a0al (2021) Experimental therapeutic approaches for the treatment of retinal dystrophy in neuronal ceroid lipofuscinosis. Ophthalmologe 118:106\u2013112","journal-title":"Ophthalmologe"},{"key":"1419_CR3","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1167\/iovs.13-12945","volume":"54","author":"U Bartsch","year":"2013","unstructured":"Bartsch\u00a0U, Galliciotti\u00a0G, Jofre\u00a0GF et\u00a0al (2013) Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis. Invest Ophthalmol Vis Sci 54:6952\u20136959","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1419_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/cells10030696","volume":"10","author":"M Bassal","year":"2021","unstructured":"Bassal\u00a0M, Liu\u00a0J, Jankowiak\u00a0W et al (2021) Rapid and progressive loss of multiple retinal cell types in cathepsin D\u2011deficient mice-an animal model of CLN10 disease. Cells 10:696","journal-title":"Cells"},{"key":"1419_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00347-020-01301-4","volume":"118","author":"V Behnke","year":"2021","unstructured":"Behnke\u00a0V, Langmann\u00a0T (2021) Neuroinflammation in neuronal ceroid lipofuscinosis. Ophthalmologe 118:98\u2013105","journal-title":"Ophthalmologe"},{"key":"1419_CR6","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1167\/iovs.16-20158","volume":"57","author":"W Jankowiak","year":"2016","unstructured":"Jankowiak\u00a0W, Brandenstein\u00a0L, Dulz\u00a0S et\u00a0al (2016) Retinal degeneration in mice deficient in the lysosomal membrane protein CLN7. Invest Ophthalmol Vis Sci 57:4989\u20134998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1419_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","volume":"15","author":"TB Johnson","year":"2019","unstructured":"Johnson\u00a0TB, Cain\u00a0JT, White\u00a0KA et\u00a0al (2019) Therapeutic landscape for Batten disease: current treatments and future prospects. Nat Rev Neurol 15:161\u2013178","journal-title":"Nat Rev Neurol"},{"key":"1419_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","volume":"33","author":"A Kohlsch\u00fctter","year":"2019","unstructured":"Kohlsch\u00fctter\u00a0A, Schulz\u00a0A, Bartsch\u00a0U et\u00a0al (2019) Current and emerging treatment strategies for neuronal ceroid lipofuscinoses. CNS Drugs 33:315\u2013325","journal-title":"CNS Drugs"},{"key":"1419_CR9","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","volume":"378","author":"A Schulz","year":"2018","unstructured":"Schulz\u00a0A, Ajayi\u00a0T, Specchio\u00a0N et\u00a0al (2018) Study of intraventricular cerliponase alfa for CLN2 disease. N\u00a0Engl J Med 378:1898\u20131907","journal-title":"N Engl J Med"},{"key":"1419_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00347-020-01304-1","volume":"118","author":"MS Spitzer","year":"2021","unstructured":"Spitzer\u00a0MS, Bartsch\u00a0U (2021) Neuronal ceroid lipofuscinoses. Ophthalmologe 118:96\u201397","journal-title":"Ophthalmologe"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01419-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-021-01419-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01419-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T09:03:29Z","timestamp":1622797409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-021-01419-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":10,"alternative-id":["1419"],"URL":"https:\/\/doi.org\/10.1007\/s00347-021-01419-z","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"assertion":[{"value":"3 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"U.\u00a0Bartsch, J.\u00a0Liu, M.\u00a0Bassal, W.\u00a0Jankowiak, M.S.\u00a0Spitzer und S.\u00a0Bartsch geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}